<< Back To Search

A Study of MCARH109 and MCARH125 in People With Multiple Myeloma

Notify the Multiple Myeloma Research Foundation You Are Interested In This Trial


Third Opinion Trial Synopsis:
Scientists will collect T cells from people and turn them into two treatments called MCARH109 and MCARH125. Some people will get only MCARH125 and others will get MCARH125 along with MCARH109.
*Third Opinion AI Generated Synopsis

Trial Summary
A sample of participants' T cells will be sent to a laboratory, where the cells will be made into the study therapy, MCARH109 and MCARH125. Participants will receive either MCARH125 alone or MCARH125 with MCARH109.

Locations & Contact

Fill out the form and "Notify Multiple Myeloma Research Foundation" to let the Multiple Myeloma Research Foundation know you are interested in this trial.

Please share any additional considerations or concerns:
Example: Are you newly diagnosed? What treatments have you already been on?